BRD 4770

Discontinued Product

6282 has been discontinued.

View all G9a/GLP products.
说明: G9a inhibitor and S-adenosyl methionine mimetic; cell permeable
化学名: Methyl-2-(benzoylamino)-1-(3-phenylpropyl)-1H-benzimidazole-5-carboxylate
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for BRD 4770

BRD 4770 is a G9a inhibitor and S-adenosyl methionine (SAM) mimetic. Inhibits methylation of H3K9 (EC50 ~ 5 μM) and induces senescence in PANC-1 cells. Induces ATM activation without DNA damage. Cell permeable.

技术数据 for BRD 4770

分子量 413.47
公式 C25H23N3O3
储存 Store at +4°C
纯度 ≥98% (HPLC)
CAS Number 1374601-40-7
PubChem ID 72193870
InChI Key UCGWYCMPZXDHNR-UHFFFAOYSA-N
Smiles COC(C1=CC=C2N(C(NC(C3=CC=CC=C3)=O)=NC2=C1)CCCC4=CC=CC=C4)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

参考文献 for BRD 4770

参考文献是支持产品生物活性的出版物。

Yuan et al (2012) A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma. ACS Chem.Biol. 7 1152 PMID: 22536950

按产品操作查看相关产品

查看全部 G9a/GLP Inhibitors

关键词: BRD 4770, BRD 4770 supplier, BRD4770, G9a, inhibitors, inhibits, EHMT2, euchromatin, histone, methyltransferase, 2, KMT1C, cell, permeable, Lysine, Methyltransferases, G9a/GLP, 6282, Tocris Bioscience

篇 BRD 4770 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 BRD 4770 的引用文献。

BRD 4770 的评论

目前没有该产品的评论。 Be the first to review BRD 4770 and earn rewards!

Have you used BRD 4770?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Epigenetics Scientific Review

Epigenetics Scientific Review

Written by Susanne Müller-Knapp and Peter J. Brown, this review gives an overview of the development of chemical probes for epigenetic targets, as well as the impact of these tool compounds being made available to the scientific community. In addition, their biological effects are also discussed. Epigenetic compounds available from Tocris are listed.

Epigenetics in Cancer Poster

Epigenetics in Cancer Poster

This poster summarizes the main epigenetic targets in cancer. The dysregulation of epigenetic modifications has been shown to result in oncogenesis and cancer progression. Unlike genetic mutations, epigenetic alterations are considered to be reversible and thus make promising therapeutic targets.